Replies to post #71743 on NanoViricides Inc. (NNVC)

[dougwur]

Informative posts, thanks. Go NNVC.

[JScott]

I'm curious about this statement:

"Once a compound has been granted orphan designation, the odds for approval are high (82%) compared to traditional drugs (35%)"

Do you know where that came from? I was looking for the supporting evidence myself and came across this:

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2012/02/the-year-of-the-orphan-orphan-drug-designations-and-approvals-hit-all-time-high-in-2011.html

Wish it were true. Or maybe I misunderstood?